Search

everythinglearnresearchcommunity

for

Search:↓

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Minoxidil helps hair regrowth in alopecia, but more research needed.

Different treatments for alopecia areata have unpredictable results and varying success rates.

Nitrogen mustard was not very effective for hair regrowth in alopecia areata and has potential skin cancer risk.

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Researchers found a new early sign of Frontal Fibrosing Alopecia that could help avoid misdiagnosis.

Recognizing congenital triangular alopecia is crucial to avoid unnecessary treatments.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

No treatment reliably changes Alopecia Areata's course; reassurance and possibly a wig are recommended.

Diphenylcyclopropenone is effective for treating alopecia areata but has a high relapse rate.

The document says a skin condition called alopecia areata causes hair loss and stress, and is treated with strong skin creams, injections, or other therapies, but treatment success varies.

Biopsy is crucial for diagnosing unusual hair loss causes like lymphoma.

5% topical minoxidil effectively treated a boy's congenital triangular alopecia without side effects.

More research is needed to find the best long-term treatments for Alopecia Areata.

Thyroid tests may not be needed for all vitiligo and alopecia areata patients unless thyroid disease symptoms appear.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

No treatment alters the natural progression of alopecia areata, and effectiveness varies, with some possibly working better in children.

Temporal triangular alopecia usually starts in early childhood and treatment with Minoxidil has limited effectiveness.

Alopecia in animals can be hereditary, congenital, or acquired, with treatments and outcomes varying widely.

Topical latanoprost and bimatoprost ophthalmic solutions don't help eyelash growth in patients with alopecia areata.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

Both mouse and rat models are effective for testing alopecia areata treatments.

Topical anthralin helped regrow hair in mice with a condition similar to human alopecia.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

CTA is often mistaken for AA but doesn't respond to steroids and may require hair transplantation.

Radiotherapy was effective for treating a large scalp plaque of Bowen's disease when other treatments failed.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.